Changing the world with a disruptive new vaccine technology pays well.
Moderna’s revolutionary role in providing the world — or at least the most affluent parts of it — with a highly effective mRNA jab for Covid-19 set the stage for CEO Stéphane Bancel’s pay to rise up to more than $18 million for last year, according to a new proxy filing.
Breaking it down, Bancel’s pay includes a $1 million salary, a $1.5 million incentive package and stock and option awards of $15 million, leaving him with the kind of income that would compare favorably with any of the top 15 Big Pharma CEOs in the world — and well above what most of the European top execs make, aside from Pascal Soriot at AstraZeneca, who came out of last year with his own personalized set of bragging rights.
Keep reading Endpoints with a free subscription
Unlock this story instantly and join 135,900+ biopharma pros reading Endpoints daily — and it’s free.